Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.8 USD | -12.39% |
|
-14.71% | -5.54% |
06-24 | Leerink Partners Upgrades Solid Biosciences to Outperform From Market Perform, Price Target is $12 | MT |
06-21 | Top Premarket Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.54% | 223M | |
+16.45% | 122B | |
+21.96% | 116B | |
+23.73% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-16.52% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Solid Biosciences Shares Fall After Surging Thursday; HC Wainwright Starts Coverage With Buy Rating